How Francophone Africa Hospitals Import UK Medicines: Algeria, Cote d'Ivoire, DRC, Senegal and Morocco

Francophone Africa covers more than twenty countries and close to 400 million people, from the Mediterranean edge of Algeria to the heart of Central Africa in the Democratic Republic of the Congo. For UK pharmaceutical suppliers and for the hospitals, importers and Ministry of Health programmes buying from them, this region is often treated as an afterthought in English-language procurement literature. In reality, the regulatory frameworks are well defined, the documentation expectations are consistent, and the supply opportunity is large and growing.

This guide is written for hospital pharmacy directors, licensed importers, procurement heads and regulatory affairs managers across Francophone Africa who source from the UK or are considering it. We cover the national regulators, the French-language documentation standards, the named patient and exceptional import pathways, and the logistics realities that shape lead times from London Heathrow to Algiers, Abidjan, Dakar, Kinshasa, Luanda and beyond. It is also relevant for UK wholesalers planning supply into a region where the assumptions from GCC or Anglophone African markets do not always transfer.

Euro Biom holds an MHRA Wholesale Dealer Authorisation, WDA(H) 59239, and supplies Francophone African hospitals and NGO programmes with branded medicines, generics, named-patient import products and shortage lines. Buyers should expect ANPP, AIRP, ACOREP, ARP and AMMPS submissions to require French-language documents.

Why Francophone Africa Looks to UK Suppliers

Francophone African hospitals have traditionally sourced from France, Belgium and North Africa-based manufacturers. Over the past five years, three pressures have shifted that pattern: unreliable post-pandemic supply from traditional European sources, the regional spread of falsified medicines that has forced procurement teams to insist on fully traceable chains of custody, and growing demand for specialty oncology and rare disease products that were never routinely stocked by local distributors.

UK wholesalers authorised under MHRA WDA sit in a useful position to fill those gaps. The WDA regime requires full Good Distribution Practice compliance, temperature-controlled storage, named Responsible Person oversight, and complete batch traceability from manufacturer to the export crate. Certificates of Pharmaceutical Product are issued by the MHRA in the WHO format, which many regulators in the region expect. Heathrow offers direct and connecting air routes, including via Paris Charles de Gaulle, to many Francophone African capitals.

For procurement teams, the choice of UK supply is rarely about price. It is about documentation quality, the ability to source locally unregistered products under named-patient import rules, and the regulatory confidence that comes from buying from a jurisdiction with active post-market surveillance and public drug alert systems.

Algeria: ANPP and the Ministere de l'Industrie Pharmaceutique

The Regulator

Algeria's pharmaceutical sector is overseen by the Ministere de l'Industrie Pharmaceutique, which was carved out as a separate ministry in 2020 to drive domestic production. Day-to-day regulatory work is run by the ANPP (Agence Nationale des Produits Pharmaceutiques), which handles marketing authorisation review and the programme d'enregistrement, while the LNCPP (Laboratoire National de Controle des Produits Pharmaceutiques) carries out laboratory quality control testing that every new medicine must pass through before reaching Algerian patients.

The state-owned PCH (Pharmacie Centrale des Hopitaux) is the central hospital procurement body for the public sector, and Saidal Group is the country's dominant domestic manufacturer. For imported specialty and oncology products, the PCH typically contracts licensed importers to source internationally, and this is where UK suppliers enter the picture. Read more about our Algeria supply service.

What Algerian Hospitals Need from a UK Supplier

Algerian hospitals and importers expect a full regulatory dossier translated into French, with the CPP, CoA, manufacturer's declaration, packaging inserts and RCP (Resume des Caracteristiques du Produit) all meeting ANPP requirements. Arabic labelling is also required for patient-facing materials on the finished product. Registration dossiers must follow the CTD format, and registration timing should be confirmed with the ANPP. For shortage or named patient lines, the exceptional import authorisation pathway is the route generally used.

Cote d'Ivoire: AIRP and the Abidjan Gateway

The Regulator

The Autorite Ivoirienne de Regulation Pharmaceutique (AIRP) is the national medicines regulator. It sits under the Ministere de la Sante, de l'Hygiene Publique et de la Couverture Maladie Universelle and holds authority over registration, inspection, pharmacovigilance, and import authorisation for all pharmaceutical products entering Cote d'Ivoire.

The Nouvelle PSP-CI (Pharmacie de la Sante Publique) is the central procurement body for public-sector hospitals. Major hospital buyers include the CHU de Cocody, CHU de Yopougon, CHU de Treichville, CHU de Bouake, PISAM and Hopital Mere-Enfant Dominique Ouattara. Read more about our Cote d'Ivoire supply service.

Why Abidjan Is a Regional Hub

Cote d'Ivoire is the economic gateway to Francophone West Africa. Felix Houphouet-Boigny International Airport and the Port of Abidjan handle significant pharmaceutical freight volumes, and the country's UEMOA membership means that cargo cleared through Abidjan can move on preferential terms into Senegal, Mali, Burkina Faso, Niger, Togo, Benin and Guinea-Bissau. Abidjan can serve as a landing point for multi-country supply across the UEMOA bloc.

Democratic Republic of the Congo: ACOREP

The Regulators

The DRC regulator is now ACOREP, which succeeded the DPM, and buyers should confirm with ACOREP which office handles each step. ACOREP (Autorite Congolaise de Reglementation Pharmaceutique) was created in 2020 as the new-generation regulator and handles authorisation, registration and inspection.

FEDECAME is the central essential medicines purchasing federation for the public sector. Major hospital buyers include the Hopital General de Kinshasa, the Cliniques Universitaires de Kinshasa and the Hopital du Cinquantenaire. The DRC is the largest Francophone African country by population and by pharmaceutical demand, and its mix of large Kinshasa tertiary hospitals, conflict-affected provinces in North Kivu, South Kivu and Ituri, and a substantial NGO-led humanitarian health sector makes it one of the most complex supply environments on the continent. Read more about our DRC supply service.

Air Freight Into the Interior

Kinshasa N'djili handles most international pharmaceutical arrivals, but domestic distribution into Goma, Bukavu and Lubumbashi often depends on internal air bridges run by specialist operators and, for humanitarian programmes, by UN agencies and NGOs. UK suppliers shipping to the DRC should plan for a split logistics route: air freight into Kinshasa with cold chain validation, followed by onward domestic distribution managed by the importing hospital or NGO.

Senegal: ARP and Dakar

The Regulator

The ARP (Agence senegalaise de Reglementation pharmaceutique) is the national medicines regulator. It is an autonomous agency created in 2022, taking over the role of the former Direction de la Pharmacie et du Medicament. Senegal is a founder UEMOA member and an influential voice in West African pharmaceutical regulatory harmonisation. Major hospital buyers include the Hopital Principal de Dakar, CHU Aristide Le Dantec and the Hopital Dalal Jamm.

Dakar is the second regional air freight gateway alongside Abidjan, and the Port of Dakar handles pharmaceutical sea freight for non-cold-chain products destined for the wider region. Read more about our Senegal supply service.

Morocco: AMMPS and the North African Gateway

The Regulator

The AMMPS (Agence Marocaine des Medicaments et des Produits de Sante) under the Ministere de la Sante sits alongside a mature domestic pharmaceutical industry. Morocco is sometimes treated as a North African market rather than a Francophone African one, but the regulatory posture is closely aligned with the rest of the region: French-language dossiers, CPPs in WHO format, and a recognised exceptional import authorisation pathway for unregistered medicines.

Casablanca is the main pharmaceutical air freight hub, with Rabat and Marrakech serving regional hospital supply. Major hospital buyers include the CHU Ibn Sina in Rabat, CHU Ibn Rochd in Casablanca, and the specialist oncology centres at the Institut National d'Oncologie. Read more about our Morocco supply service.

Documentation Standard for Francophone Africa

Whichever country you are shipping into, the core documentation package a UK supplier should prepare looks broadly the same. Small country-specific variations exist, but a well-prepared base package covers most of any submission.

Named Patient and Exceptional Import Pathways

Every Francophone African regulator has a version of the named patient or exceptional import pathway for medicines not registered locally. The legal terminology varies, but the underlying principle is consistent: a specific patient or patient group has a documented clinical need, no suitable alternative is registered, and the hospital or importer is authorised to bring in the unregistered product for that specific use.

These pathways are used most often for specialty oncology medicines, rare disease medicines, paediatric specialty formulations, emergency antimicrobials, and medicines experiencing temporary regional shortage. The UK supplier's role is to provide the product dossier, CPP and manufacturer declaration, together with a certificate of analysis where the manufacturer makes one available, within a timeframe that allows the importing hospital to submit a complete authorisation request. Our named-patient import supply service is built specifically for this workflow, with UK-side documents supplied for the buyer to translate and submit.

Logistics: UK to Francophone Africa

Direct and one-stop air freight from London Heathrow reaches every major Francophone African capital. Typical transit times for cleared, properly documented consignments are: Algiers under six hours, Casablanca under four hours, Dakar under seven hours, Abidjan under nine hours, Kinshasa under twelve hours, Luanda under twelve hours. Most of the end-to-end lead time is consumed by documentation preparation and in-country customs rather than flight time.

2-8°C medicines are shipped from our contract storage site in temperature-controlled packaging with a data logger, arranged with specialist carriers. For shortage and named patient work, lines are confirmed with licensed UK sources in advance so that typical dispatch is within 24 to 72 hours of order confirmation, subject to availability.

Who We Supply in Francophone Africa

Euro Biom can supply three customer groups in the region. First, hospital pharmacy directors and tertiary hospital procurement teams sourcing specialty, oncology and named patient medicines. Second, licensed importers and distributors that serve national essential medicines lists and private-sector pharmacy chains. Third, international NGOs and humanitarian programmes operating in Sudan, eastern DRC, Sahel countries and other crisis contexts where conventional supply chains do not reliably deliver.

Our core compliance posture, MHRA WDA(H) 59239, GDP-compliant storage, named Responsible Person oversight, and support for MHRA-issued WHO-format CPPs, is consistent across every customer type. What changes is the documentation workflow, the import authorisation pathway, and the logistics routing.

Common Questions from Francophone African Buyers

How do we start an enquiry with a UK supplier?

Send a product list with INN names, strengths and quantities, plus the destination country and buyer type (public hospital, private distributor, NGO programme). A UK supplier should respond within one working day with availability, approximate pricing and a documentation scope. For named patient requests, include the treating physician's letter and any supporting clinical documentation.

Can a UK supplier ship without an in-country agent?

Most Francophone African regulators require a locally licensed importer or hospital pharmacy to hold the import authorisation. The UK supplier ships on FCA or CPT terms to that local party, who handles in-country clearance. A UK supplier cannot hold the import authorisation directly.

What about pricing?

UK-sourced specialty medicines are typically priced above the lowest-cost local alternatives, which reflects the cost of MHRA-licensed storage, GDP-compliant handling, WHO-format documentation and air freight via Heathrow. The procurement case for UK supply is built on documentation quality, traceability and named patient availability, not on being the cheapest source.

What happens when an import is refused at the border?

Most refusals result from documentation gaps: missing French translations, CPP issued in the wrong format, CoA that does not reference the shipped batch, or incomplete cold chain records. A UK supplier with experience in the region should build the documentation pack to survive first-pass regulator inspection. When a refusal happens, the hospital or importer requests the specific deficiency note, the UK supplier prepares the corrective document, and the shipment is re-presented. Allow three to seven working days for the correction cycle.

Frequently Asked Questions

Which regulatory bodies control pharmaceutical imports in Francophone Africa?

Each Francophone African country has its own national medicines regulator. Algeria uses the ANPP (Agence Nationale des Produits Pharmaceutiques) and the Ministere de l'Industrie Pharmaceutique. Cote d'Ivoire uses the AIRP (Autorite Ivoirienne de Regulation Pharmaceutique). The Democratic Republic of the Congo uses ACOREP. Senegal's medicines regulator is the ARP (Agence senegalaise de Reglementation pharmaceutique), which replaced the former Direction de la Pharmacie et du Medicament in 2022. Morocco uses the AMMPS (Agence Marocaine des Medicaments et des Produits de Sante) under the Ministry of Health and Social Protection. UEMOA and ECOWAS provide some regional harmonisation across West African members, but registration is still done country by country.

Does a UK pharmaceutical supplier need to provide documentation in French?

Yes. All major regulatory submissions and import dossiers in Francophone Africa must be in French. The Certificate of Pharmaceutical Product (CPP), product information leaflets, SPC/RCP summaries, commercial documentation, and any certificate of analysis the manufacturer supplies for the batch, all need a French version. A UK supplier should arrange certified French translations of the WHO-format CPP and supporting documents before submission. Euro Biom can pass on UK-side documents such as the CPP and product information where the issuer makes them available, for the buyer to translate and submit.

Can hospitals in Francophone Africa import medicines not yet registered locally from the UK on a named patient basis?

Yes. Most Francophone African regulators recognise a named patient or autorisation d'importation exceptionnelle pathway for medicines not registered locally, provided there is documented clinical need and no suitable registered alternative. The pathway is used most often for specialty oncology medicines, rare disease medicines, paediatric specialty formulations and medicines experiencing regional shortage. The UK supplier provides a product dossier, CPP and manufacturer declaration, together with a certificate of analysis where the manufacturer makes one available, and the importing hospital or licensed distributor submits the exceptional import authorisation request to the national regulator.

How long does it take to ship medicines from the UK to Francophone Africa?

Direct and one-stop flights from London Heathrow serve Algiers, Casablanca, Abidjan, Dakar, Kinshasa and Luanda. Transit times depend on carrier routing and customs clearance; we confirm an estimate with each quote. Most of the variation comes from in-country customs clearance and regulatory inspection rather than air freight time. Emergency enquiries receive a response within 4 hours, and typical dispatch is within 24 to 72 hours of order confirmation, subject to availability.

What is the UEMOA role in Francophone West African pharmaceutical supply?

UEMOA (Union Economique et Monetaire Ouest-Africaine) coordinates economic and customs policy across eight Francophone West African states, including Cote d'Ivoire, Senegal, Burkina Faso, Mali, Benin, Togo, Niger and Guinea-Bissau. For pharmaceutical supply, UEMOA provides a common external tariff and some harmonisation of customs procedures, but medicines registration and import authorisation remain national. In practice this means a single UK shipment can enter the region through Abidjan or Dakar and then move under UEMOA customs rules, but each destination country still requires its own import permit and regulatory clearance.